Asthma, COPD Do Not Increase Mortality Risk in Patients With COVID-19
Asthma and chronic obstructive pulmonary disease (COPD) do not appear to increase the risk of mortality in patients with COVID-19.
COPD
Reduced All-Cause Mortality in COPD With Budesonide/ Glycopyrrolate/ Formoterol
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate may reduce the risk of death compared with glycopyrrolate/formoterol fumarate in patients with COPD.
ATS Issues Recommendations for Noninvasive Ventilation in COPD
Recommendations are presented for the use of noninvasive ventilation for patients with COPD and chronic hypercapnia in an American Thoracic Society clinical practice guideline.
Dupilumab Improves Lung Function in CRSwNP and Comorbid Asthma and COPD Features
Treatment with dupilumab led to significant improvements in lung function by 16 weeks and up to 24 weeks in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma plus clinical features of COPD.
Breztri Aerosphere Approved as Triple-Combination Therapy Inhaler for COPD
The FDA has approved Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate; AstraZeneca) for the maintenance treatment of chronic obstructive pulmonary disease.
Triple Inhaled Therapy Aids in Moderate-to-Very Severe COPD
Triple therapy, including glucocorticoid at either of 2 dose levels, is beneficial for moderate-to-very severe chronic obstructive pulmonary disease.
Asthma, COPD Medication Adherence Up During Pandemic
Medication adherence for asthma and chronic obstructive pulmonary disease has increased during the COVID-19 pandemic,
Risk of COPD In-Hospital Mortality Linked to Atrial Fibrillation
In patients hospitalized for COPD exacerbation, the presence of atrial fibrillation may increase the risk of in-hospital mortality.
Home Noninvasive Positive Pressure Ventilation May Improve Certain Outcomes in COPD
In patients with COPD and hypercapnia, the use of home noninvasive positive pressure ventilation compared with no device was significantly associated with improved clinical outcomes but no significant differences in quality of life.
Young patients with COPD still active smokers
Patients who are socioeconomically disadvantaged are more likely to continue smoking after a COPD diagnosis.
- Loading...
Loading...
Loading... 
Loading...